Exercise in Neuromuscular Disease

 

 Buy Article Permissions and Reprints

Abstract

In this review, the authors present an overview of the role of exercise in neuromuscular disease (NMD). The authors demonstrate that despite the different pathologies in NMDs, exercise is beneficial, whether aerobic/endurance or strength/resistive training. The authors analyze methodological flaws of existing studies and suggest improvements for future trial protocols. Finally, we discuss specialized exercise training of specific muscles, as well as new technologies adapted from other neurologic disorders, including body-weight-supported treadmill ambulation, robotic-assisted gait training, and neuromuscular electrical stimulation.

• References

• 1 Handschin C, Spiegelman BM. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 2008; 454 (7203) 463-469
  CrossrefPubMedGoogle Scholar
• 2 Deforges S, Branchu J, Biondi O , et al. Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. J Physiol 2009; 587 (Pt 14) 3561-3572
  CrossrefPubMedGoogle Scholar
• 3 Liebetanz D, Hagemann K, von Lewinski F, Kahler E, Paulus W. Extensive exercise is not harmful in amyotrophic lateral sclerosis. Eur J Neurosci 2004; 20 (11) 3115-3120
  CrossrefPubMedGoogle Scholar
• 4 Dal Bello-Haas V, Florence JM. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst Rev 2013; 5 (5) CD005229
  PubMedGoogle Scholar
• 5 Pinto AC, Alves M, Nogueira A , et al. Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise?. J Neurol Sci 1999; 169 (1-2) 69-75
  CrossrefPubMedGoogle Scholar
• 6 van Groenestijn AC, van de Port IG, Schröder CD , et al. Effects of aerobic exercise therapy and cognitive behavioural therapy on functioning and quality of life in amyotrophic lateral sclerosis: protocol of the FACTS-2-ALS trial. BMC Neurol 2011; 11: 70
  CrossrefPubMedGoogle Scholar
• 7 Pinto S, Swash M, de Carvalho M. Respiratory exercise in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2012; 13 (1) 33-43
  CrossrefPubMedGoogle Scholar
• 8 Cheah BC, Boland RA, Brodaty NE , et al. INSPIRATIonAL—INSPIRAtory muscle training in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009; 10 (5-6) 384-392
  CrossrefPubMedGoogle Scholar
• 9 Preisler N, Andersen G, Thøgersen F , et al. Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease). Neurology 2009; 72 (4) 317-323
  CrossrefPubMedGoogle Scholar
• 10 Fischbeck KH. Effect of functional exercise in patients with spinal and bulbar muscular atrophy. NCT01369901. Available at: http://clinicaltrials.gov . Accessed November 1, 2014
  PubMedGoogle Scholar
• 11 Grondard C, Biondi O, Armand AS , et al. Regular exercise prolongs survival in a type 2 spinal muscular atrophy model mouse. J Neurosci 2005; 25 (33) 7615-7622
  CrossrefPubMedGoogle Scholar
• 12 Biondi O, Grondard C, Lécolle S , et al. Exercise-induced activation of NMDA receptor promotes motor unit development and survival in a type 2 spinal muscular atrophy model mouse. J Neurosci 2008; 28 (4) 953-962
  CrossrefPubMedGoogle Scholar
• 13 Charbonnier F. Exercise-induced neuroprotection in SMA model mice: a means for determining new therapeutic strategies. Mol Neurobiol 2007; 35 (3) 217-223 Review
  CrossrefPubMedGoogle Scholar
• 14 Montes J, Kramer S, Dunaway SA. Single-blind, randomized, controlled clinical trial of exercise in ambulatory spinal muscular atrophy (SMA) patients. NCT01166022. Available at: http://clinicaltrials.gov . Accessed November 1, 2014
  PubMedGoogle Scholar
• 15 Salem Y, Gropack SJ. Aquatic therapy for a child with type III spinal muscular atrophy: a case report. Phys Occup Ther Pediatr 2010; 30 (4) 313-324
  CrossrefPubMedGoogle Scholar
• 16 Carter GT, Abresch RT, Fowler Jr WM, Johnson ER, Kilmer DD, McDonald CM. Profiles of neuromuscular diseases. Hereditary motor and sensory neuropathy, types I and II. Am J Phys Med Rehabil 1995; 74 (5, Suppl): S140-S149
  CrossrefPubMedGoogle Scholar
• 17 Menotti F, Felici F, Damiani A, Mangiola F, Vannicelli R, Macaluso A. Charcot-Marie-Tooth 1A patients with low level of impairment have a higher energy cost of walking than healthy individuals. Neuromuscul Disord 2011; 21 (1) 52-57
  CrossrefPubMedGoogle Scholar
• 18 Ramdharry GM, Day BL, Reilly MM, Marsden JF. Hip flexor fatigue limits walking in Charcot-Marie-Tooth disease. Muscle Nerve 2009; 40 (1) 103-111
  CrossrefPubMedGoogle Scholar
• 19 Vinci P. Strengthening of the proximal muscles in Charcot-Marie-Tooth disease. Arch Phys Med Rehabil 2001; 82 (4) 563
  CrossrefPubMedGoogle Scholar
• 20 Lindeman E, Leffers P, Spaans F , et al. Strength training in patients with myotonic dystrophy and hereditary motor and sensory neuropathy: a randomized clinical trial. Arch Phys Med Rehabil 1995; 76 (7) 612-620
  CrossrefPubMedGoogle Scholar
• 21 Chetlin RD, Gutmann L, Tarnopolsky M, Ullrich IH, Yeater RA. Resistance training effectiveness in patients with Charcot-Marie-Tooth disease: recommendations for exercise prescription. Arch Phys Med Rehabil 2004; 85 (8) 1217-1223
  CrossrefPubMedGoogle Scholar
• 22 Maggi G, Monti Bragadin M, Padua L , et al. Outcome measures and rehabilitation treatment in patients affected by Charcot-Marie-Tooth neuropathy: a pilot study. Am J Phys Med Rehabil 2011; 90 (8) 628-637
  CrossrefPubMedGoogle Scholar
• 23 El Mhandi L, Pichot V, Calmels P, Gautheron V, Roche F, Féasson L. Exercise training improves autonomic profiles in patients with Charcot-Marie-Tooth disease. Muscle Nerve 2011; 44 (5) 732-736
  CrossrefPubMedGoogle Scholar
• 24 El Mhandi L, Millet GY, Calmels P , et al. Benefits of interval-training on fatigue and functional capacities in Charcot-Marie-Tooth disease. Muscle Nerve 2008; 37 (5) 601-610
  CrossrefPubMedGoogle Scholar
• 25 Lohi EL, Lindberg C, Andersen O. Physical training effects in myasthenia gravis. Arch Phys Med Rehabil 1993; 74 (11) 1178-1180
  PubMedGoogle Scholar
• 26 Stout JR, Eckerson JM, May E, Coulter C, Bradley-Popovich GE. Effects of resistance exercise and creatine supplementation on myasthenia gravis: a case study. Med Sci Sports Exerc 2001; 33 (6) 869-872
  CrossrefPubMedGoogle Scholar
• 27 Scheer BV, Valero-Burgos E, Costa R. Myasthenia gravis and endurance exercise. Am J Phys Med Rehabil 2012; 91 (8) 725-727
  CrossrefPubMedGoogle Scholar
• 28 Lucia A, Maté-Muñoz JL, Pérez M, Foster C, Gutiérrez-Rivas E, Arenas J. Double trouble (McArdle's disease and myasthenia gravis): how can exercise help?. Muscle Nerve 2007; 35 (1) 125-128
  CrossrefPubMedGoogle Scholar
• 29 Fregonezi GA, Resqueti VR, Güell R, Pradas J, Casan P. Effects of 8-week, interval-based inspiratory muscle training and breathing retraining in patients with generalized myasthenia gravis. Chest 2005; 128 (3) 1524-1530
  CrossrefPubMedGoogle Scholar
• 30 Rassler B, Hallebach G, Kalischewski P, Baumann I, Schauer J, Spengler CM. The effect of respiratory muscle endurance training in patients with myasthenia gravis. Neuromuscul Disord 2007; 17 (5) 385-391
  CrossrefPubMedGoogle Scholar
• 31 Rassler B, Marx G, Hallebach S, Kalischewski P, Baumann I. Long-term respiratory muscle endurance training in patients with myasthenia gravis: first results after four months of training. Autoimmune Dis 2011; ; Article ID 808607
  PubMedGoogle Scholar
• 32 Cass S. Myasthenia gravis and sports participation. Curr Sports Med Rep 2013; 12 (1) 18-21
  CrossrefPubMedGoogle Scholar
• 33 Vissing J, van Engelen BG. 160th ENMC International Workshop (First ENMC practical care workshop) Exercise training in patients with muscle diseases: 20-22 June 2008, Naarden, The Netherlands. Neuromuscul Disord 2013; 23 (2) 182-187
  CrossrefPubMedGoogle Scholar
• 34 Voet NB, van der Kooi EL, Riphagen II, Lindeman E, van Engelen BG, Geurts AC. Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst Rev 2013; 7: CD003907
  PubMedGoogle Scholar
• 35 Cejudo P, Bautista J, Montemayor T , et al. Exercise training in mitochondrial myopathy: a randomized controlled trial. Muscle Nerve 2005; 32 (3) 342-350
  CrossrefPubMedGoogle Scholar
• 36 van der Kooi EL, Vogels OJ, van Asseldonk RJ , et al. Strength training and albuterol in facioscapulohumeral muscular dystrophy. Neurology 2004; 63 (4) 702-708
  CrossrefPubMedGoogle Scholar
• 37 Wiesinger GF, Quittan M, Aringer M , et al. Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme. Br J Rheumatol 1998; 37 (2) 196-200
  CrossrefPubMedGoogle Scholar
• 38 Kierkegaard M, Harms-Ringdahl K, Edström L, Widén Holmqvist L, Tollbäck A. Feasibility and effects of a physical exercise programme in adults with myotonic dystrophy type 1: a randomized controlled pilot study. J Rehabil Med 2011; 43 (8) 695-702
  CrossrefPubMedGoogle Scholar
• 39 Markert CD, Ambrosio F, Call JA, Grange RW. Exercise and Duchenne muscular dystrophy: toward evidence-based exercise prescription. Muscle Nerve 2011; 43 (4) 464-478
  CrossrefPubMedGoogle Scholar
• 40 Hayes A, Williams DA. Beneficial effects of voluntary wheel running on the properties of dystrophic mouse muscle. J Appl Physiol (1985) 1996; 80 (2) 670-679
  PubMedGoogle Scholar
• 41 Wineinger MA, Abresch RT, Walsh SA, Carter GT. Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice. Am J Phys Med Rehabil 1998; 77 (1) 20-27
  CrossrefPubMedGoogle Scholar
• 42 Carter GT, Abresch RT, Fowler Jr WM. Adaptations to exercise training and contraction-induced muscle injury in animal models of muscular dystrophy. Am J Phys Med Rehabil 2002; 81 (11, Suppl): S151-S161
  CrossrefPubMedGoogle Scholar
• 43 Vignos Jr PJ, Watkins MP. The effect of exercise in muscular dystrophy. JAMA 1966; 197 (11) 843-848
  CrossrefPubMedGoogle Scholar
• 44 Scott OM, Hyde SA, Goddard C, Jones R, Dubowitz V. Effect of exercise in Duchenne muscular dystrophy. Physiotherapy 1981; 67 (6) 174-176
  PubMedGoogle Scholar
• 45 de Lateur BJ, Giaconi RM. Effect on maximal strength of submaximal exercise in Duchenne muscular dystrophy. Am J Phys Med 1979; 58 (1) 26-36
  PubMedGoogle Scholar
• 46 Jansen M, van Alfen N, Geurts AC, de Groot IJ. Assisted bicycle training delays functional deterioration in boys with Duchenne muscular dystrophy: the randomized controlled trial “no use is disuse”. Neurorehabil Neural Repair 2013; 27 (9) 816-827
  CrossrefPubMedGoogle Scholar
• 47 Sveen ML, Jeppesen TD, Hauerslev S, Køber L, Krag TO, Vissing J. Endurance training improves fitness and strength in patients with Becker muscular dystrophy. Brain 2008; 131 (Pt 11) 2824-2831
  CrossrefPubMedGoogle Scholar
• 48 Topin N, Matecki S, Le Bris S , et al. Dose-dependent effect of individualized respiratory muscle training in children with Duchenne muscular dystrophy. Neuromuscul Disord 2002; 12 (6) 576-583
  CrossrefPubMedGoogle Scholar
• 49 Tollbäck A, Eriksson S, Wredenberg A , et al. Effects of high resistance training in patients with myotonic dystrophy. Scand J Rehabil Med 1999; 31 (1) 9-16
  CrossrefPubMedGoogle Scholar
• 50 Aldehag AS, Jonsson H, Ansved T. Effects of a hand training programme in five patients with myotonic dystrophy type 1. Occup Ther Int 2005; 12 (1) 14-27
  CrossrefPubMedGoogle Scholar
• 51 Aldehag A, Jonsson H, Lindblad J, Kottorp A, Ansved T, Kierkegaard M. Effects of hand-training in persons with myotonic dystrophy type 1—a randomised controlled cross-over pilot study. Disabil Rehabil 2013; 35 (21) 1798-1807
  CrossrefPubMedGoogle Scholar
• 52 Orngreen MC, Olsen DB, Vissing J. Aerobic training in patients with myotonic dystrophy type 1. Ann Neurol 2005; 57 (5) 754-757
  CrossrefPubMedGoogle Scholar
• 53 Trenell MI, Thompson CH, Sue CM. Exercise and myotonic dystrophy: a 31P magnetic resonance spectroscopy and magnetic resonance imaging case study. Ann Neurol 2006; 59 (5) 871-872
  PubMedGoogle Scholar
• 54 Missaoui B, Rakotovao E, Bendaya S , et al. Posture and gait abilities in patients with myotonic dystrophy (Steinert disease). Evaluation on the short-term of a rehabilitation program. Ann Phys Rehabil Med 2010; 53 (6-7) 387-398
  CrossrefPubMedGoogle Scholar
• 55 Sveen ML, Andersen SP, Ingelsrud LH , et al. Resistance training in patients with limb-girdle and Becker muscular dystrophies. Muscle Nerve 2013; 47 (2) 163-169
  CrossrefPubMedGoogle Scholar
• 56 Sveen ML, Jeppesen TD, Hauerslev S, Krag TO, Vissing J. Endurance training: an effective and safe treatment for patients with LGMD2I. Neurology 2007; 68 (1) 59-61
  CrossrefPubMedGoogle Scholar
• 57 Colson SS, Benchortane M, Tanant V , et al. Neuromuscular electrical stimulation training: a safe and effective treatment for facioscapulohumeral muscular dystrophy patients. Arch Phys Med Rehabil 2010; 91 (5) 697-702
  CrossrefPubMedGoogle Scholar
• 58 van der Kooi EL, Kalkman JS, Lindeman E , et al. Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy. J Neurol 2007; 254 (7) 931-940
  CrossrefPubMedGoogle Scholar
• 59 Olsen DB, Ørngreen MC, Vissing J. Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy. Neurology 2005; 64 (6) 1064-1066
  CrossrefPubMedGoogle Scholar
• 60 Voet NB, Bleijenberg G, Padberg GW, van Engelen BG, Geurts AC. Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trial. BMC Neurol 2010; 10: 56
  CrossrefPubMedGoogle Scholar
• 61 National Cancer Institute. PI: Physical training introduction in lifestyle of facioscapulohumeral dystrophy patients. NCT01116570. Available at: http://clinicaltrials.gov . Accessed November 1, 2014
  PubMedGoogle Scholar
• 62 Féasson L, Verney J, Kadi F, Gautheron V, Calmels P, Millet GY. [Exercise therapy and myopathies]. Rev Neurol (Paris) 2010; 166 (3) 269-278
  CrossrefPubMedGoogle Scholar
• 63 Cup EH, Pieterse AJ, Ten Broek-Pastoor JM , et al. Exercise therapy and other types of physical therapy for patients with neuromuscular diseases: a systematic review. Arch Phys Med Rehabil 2007; 88 (11) 1452-1464
  CrossrefPubMedGoogle Scholar
• 64 van der Kooi EL, Lindeman E, Riphagen I. Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst Rev 2005; 1 (1) CD003907
  PubMedGoogle Scholar
• 65 Wiesinger GF, Quittan M, Nuhr M , et al. Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls. Arch Phys Med Rehabil 2000; 81 (1) 1-5
  CrossrefPubMedGoogle Scholar
• 66 Henriksson KG, Lindvall B. Polymyositis and dermatomyositis 1990—diagnosis, treatment and prognosis. Prog Neurobiol 1990; 35 (3) 181-193
  CrossrefPubMedGoogle Scholar
• 67 Escalante A, Miller L, Beardmore TD. Resistive exercise in the rehabilitation of polymyositis/dermatomyositis. J Rheumatol 1993; 20 (8) 1340-1344
  PubMedGoogle Scholar
• 68 Wiesinger GF, Quittan M, Graninger M , et al. Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients. Br J Rheumatol 1998; 37 (12) 1338-1342
  CrossrefPubMedGoogle Scholar
• 69 Dalise S, Bertolucci F, Simonella C, Rossi B, Chisari C. Intensive aerobic training improves motor performances and oxidative metabolism efficiency in chronic polymyositis: a case report. Neuromuscul Disord 2012; 22 (Suppl. 03) S221-S225
  CrossrefPubMedGoogle Scholar
• 70 Alexanderson H, Stenström CH, Lundberg I. Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study. Rheumatology (Oxford) 1999; 38 (7) 608-611
  CrossrefPubMedGoogle Scholar
• 71 Johnson LG, Collier KE, Edwards DJ , et al. Improvement in aerobic capacity after an exercise program in sporadic inclusion body myositis. J Clin Neuromuscul Dis 2009; 10 (4) 178-184
  CrossrefPubMedGoogle Scholar
• 72 Arnardottir S, Alexanderson H, Lundberg IE, Borg K. Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction. J Rehabil Med 2003; 35 (1) 31-35
  CrossrefPubMedGoogle Scholar
• 73 Spector SA, Lemmer JT, Koffman BM , et al. Safety and efficacy of strength training in patients with sporadic inclusion body myositis. Muscle Nerve 1997; 20 (10) 1242-1248
  CrossrefPubMedGoogle Scholar
• 74 Habers GE, Takken T. Safety and efficacy of exercise training in patients with an idiopathic inflammatory myopathy—a systematic review. Rheumatology (Oxford) 2011; 50 (11) 2113-2124
  CrossrefPubMedGoogle Scholar
• 75 Haller RG, Lewis SF, Cook JD, Blomqvist CG. Myophosphorylase deficiency impairs muscle oxidative metabolism. Ann Neurol 1985; 17 (2) 196-199
  CrossrefPubMedGoogle Scholar
• 76 Dandurand RJ, Matthews PM, Arnold DL, Eidelman DH. Mitochondrial disease. Pulmonary function, exercise performance, and blood lactate levels. Chest 1995; 108 (1) 182-189
  CrossrefPubMedGoogle Scholar
• 77 Lindholm H, Löfberg M, Somer H, Näveri H, Sovijärvi A. Abnormal blood lactate accumulation after exercise in patients with multiple mitochondrial DNA deletions and minor muscular symptoms. Clin Physiol Funct Imaging 2004; 24 (2) 109-115
  CrossrefPubMedGoogle Scholar
• 78 Taivassalo T, Shoubridge EA, Chen J , et al. Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects. Ann Neurol 2001; 50 (2) 133-141
  CrossrefPubMedGoogle Scholar
• 79 Jeppesen TD, Schwartz M, Olsen DB , et al. Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy. Brain 2006; 129 (Pt 12) 3402-3412
  CrossrefPubMedGoogle Scholar
• 80 Taivassalo T, De Stefano N, Chen J, Karpati G, Arnold DL, Argov Z. Short-term aerobic training response in chronic myopathies. Muscle Nerve 1999; 22 (9) 1239-1243
  CrossrefPubMedGoogle Scholar
• 81 Taivassalo T, Gardner JL, Taylor RW , et al. Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. Brain 2006; 129 (Pt 12) 3391-3401
  CrossrefPubMedGoogle Scholar
• 82 Jeppesen TD, Dunø M, Schwartz M , et al. Short- and long-term effects of endurance training in patients with mitochondrial myopathy. Eur J Neurol 2009; 16 (12) 1336-1339
  CrossrefPubMedGoogle Scholar
• 83 Hood DA. Invited review: contractile activity-induced mitochondrial biogenesis in skeletal muscle. J Appl Physiol (1985) 2001; 90 (3) 1137-1157
  PubMedGoogle Scholar
• 84 Taivassalo T, Haller RG. Exercise and training in mitochondrial myopathies. Med Sci Sports Exerc 2005; 37 (12) 2094-2101
  CrossrefPubMedGoogle Scholar
• 85 Case LE, Kishnani PS. Physical therapy management of Pompe disease. Genet Med 2006; 8 (5) 318-327
  CrossrefPubMedGoogle Scholar
• 86 Cupler EJ, Berger KI, Leshner RT , et al; AANEM Consensus Committee on Late-onset Pompe Disease. Consensus treatment recommendations for late-onset Pompe disease. Muscle Nerve 2012; 45 (3) 319-333
  CrossrefPubMedGoogle Scholar
• 87 Case LE, Beckemeyer AA, Kishnani PS. Infantile Pompe disease on ERT: update on clinical presentation, musculoskeletal management, and exercise considerations. Am J Med Genet C Semin Med Genet 2012; 160C (1) 69-79
  CrossrefPubMedGoogle Scholar
• 88 Slonim AE, Bulone L, Goldberg T , et al. Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve 2007; 35 (1) 70-77
  CrossrefPubMedGoogle Scholar
• 89 Terzis G, Dimopoulos F, Papadimas GK , et al. Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy. Mol Genet Metab 2011; 104 (3) 279-283
  CrossrefPubMedGoogle Scholar
• 90 Jones HN, Moss T, Edwards L, Kishnani PS. Increased inspiratory and expiratory muscle strength following respiratory muscle strength training (RMST) in two patients with late-onset Pompe disease. Mol Genet Metab 2011; 104 (3) 417-420
  CrossrefPubMedGoogle Scholar
• 91 Vissing J, Haller RG. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease. N Engl J Med 2003; 349 (26) 2503-2509
  CrossrefPubMedGoogle Scholar
• 92 De Stefano N, Argov Z, Matthews PM, Karpati G, Arnold DL. Impairment of muscle mitochondrial oxidative metabolism in McArdles's disease. Muscle Nerve 1996; 19 (6) 764-769
  CrossrefPubMedGoogle Scholar
• 93 Vissing J, Vissing SF, MacLean DA, Saltin B, Quistorff B, Haller RG. Sympathetic activation in exercise is not dependent on muscle acidosis. Direct evidence from studies in metabolic myopathies. J Clin Invest 1998; 101 (8) 1654-1660
  CrossrefPubMedGoogle Scholar
• 94 García-Benítez S, Fleck SJ, Naclerio F, Martín MA, Lucia A. Resistance (weight lifting) training in an adolescent with McArdle disease. J Child Neurol 2013; 28 (6) 805-808
  CrossrefPubMedGoogle Scholar
• 95 Haller RG, Wyrick P, Taivassalo T, Vissing J. Aerobic conditioning: an effective therapy in McArdle's disease. Ann Neurol 2006; 59 (6) 922-928
  CrossrefPubMedGoogle Scholar
• 96 Maté-Muñoz JL, Moran M, Pérez M , et al. Favorable responses to acute and chronic exercise in McArdle patients. Clin J Sport Med 2007; 17 (4) 297-303
  CrossrefPubMedGoogle Scholar
• 97 Ollivier K, Hogrel JY, Gomez-Merino D , et al. Exercise tolerance and daily life in McArdle's disease. Muscle Nerve 2005; 31 (5) 637-641
  CrossrefPubMedGoogle Scholar
• 98 Quinlivan R, Vissing J, Hilton-Jones D, Buckley J. Physical training for McArdle disease. Cochrane Database Syst Rev 2011; 12 (12) CD007931
  PubMedGoogle Scholar
• 99 Sackley C, Disler PB, Turner-Stokes L, Wade DT, Brittle N, Hoppitt T. Rehabilitation interventions for foot drop in neuromuscular disease. Cochrane Database Syst Rev 2009; 3 (3) CD003908
  PubMedGoogle Scholar
• 100 Weiner P, Gross D, Meiner Z , et al. Respiratory muscle training in patients with moderate to severe myasthenia gravis. Can J Neurol Sci 1998; 25 (3) 236-241
  PubMedGoogle Scholar
• 101 Salsabili H, Bahrpeyma F, Forogh B, Rajabali S. Dynamic stability training improves standing balance control in neuropathic patients with type 2 diabetes. J Rehabil Res Dev 2011; 48 (7) 775-786
  CrossrefPubMedGoogle Scholar
• 102 Wong SH, Nitz JC, Williams K, Brauer SG. Effects of balance strategy training in myasthenia gravis: a case study series. Muscle Nerve 2014; 49 (5) 654-660
  CrossrefPubMedGoogle Scholar
• 103 Au-Yeung SS, Hui-Chan CW, Tang JC. Short-form Tai Chi improves standing balance of people with chronic stroke. Neurorehabil Neural Repair 2009; 23 (5) 515-522
  CrossrefPubMedGoogle Scholar
• 104 Voukelatos A, Cumming RG, Lord SR, Rissel C. A randomized, controlled trial of tai chi for the prevention of falls: the Central Sydney tai chi trial. J Am Geriatr Soc 2007; 55 (8) 1185-1191
  CrossrefPubMedGoogle Scholar
• 105 Lan C, Lai JS, Chen SY, Wong MK. Tai Chi Chuan to improve muscular strength and endurance in elderly individuals: a pilot study. Arch Phys Med Rehabil 2000; 81 (5) 604-607
  CrossrefPubMedGoogle Scholar
• 106 Johnson CR. Aquatic therapy for an ALS patient. Am J Occup Ther 1988; 42 (2) 115-120
  CrossrefPubMedGoogle Scholar
• 107 Sanjak M, Bravver E, Bockenek WL, Norton HJ, Brooks BR. Supported treadmill ambulation for amyotrophic lateral sclerosis: a pilot study. Arch Phys Med Rehabil 2010; 91 (12) 1920-1929
  CrossrefPubMedGoogle Scholar
• 108 Kurz MJ, Stuberg W, DeJong SL. Body weight supported treadmill training improves the regularity of the stepping kinematics in children with cerebral palsy. Dev Neurorehabil 2011; 14 (2) 87-93
  CrossrefPubMedGoogle Scholar
• 109 Banala SK, Kim SH, Agrawal SK, Scholz JP. Robot assisted gait training with active leg exoskeleton (ALEX). IEEE Trans Neural Syst Rehabil Eng 2009; 17 (1) 2-8
  CrossrefPubMedGoogle Scholar
• 110 Mehrholz J, Werner C, Kugler J, Pohl M. Electromechanical-assisted training for walking after stroke. Cochrane Database Syst Rev 2007; 4 (4) CD006185
  PubMedGoogle Scholar
• 111 Mehrholz J, Pohl M, Elsner B. Treadmill training and body weight support for walking after stroke. Cochrane Database Syst Rev 2014; 1: CD002840
  PubMedGoogle Scholar
• 112 Gerovasili V, Stefanidis K, Vitzilaios K , et al. Electrical muscle stimulation preserves the muscle mass of critically ill patients: a randomized study. Crit Care 2009; 13 (5) R161
  CrossrefPubMedGoogle Scholar
• 113 Gibson JN, Smith K, Rennie MJ. Prevention of disuse muscle atrophy by means of electrical stimulation: maintenance of protein synthesis. Lancet 1988; 2 (8614) 767-770
  PubMedGoogle Scholar
• 114 Maffiuletti NA. Physiological and methodological considerations for the use of neuromuscular electrical stimulation. Eur J Appl Physiol 2010; 110 (2) 223-234
  CrossrefPubMedGoogle Scholar
• 115 Nosaka K, Aldayel A, Jubeau M, Chen TC. Muscle damage induced by electrical stimulation. Eur J Appl Physiol 2011; 111 (10) 2427-2437
  CrossrefPubMedGoogle Scholar
• 116 Theurel J, Lepers R, Pardon L, Maffiuletti NA. Differences in cardiorespiratory and neuromuscular responses between voluntary and stimulated contractions of the quadriceps femoris muscle. Respir Physiol Neurobiol 2007; 157 (2-3) 341-347
  CrossrefPubMedGoogle Scholar
• 117 Stevens JE, Mizner RL, Snyder-Mackler L. Neuromuscular electrical stimulation for quadriceps muscle strengthening after bilateral total knee arthroplasty: a case series. J Orthop Sports Phys Ther 2004; 34 (1) 21-29
  CrossrefPubMedGoogle Scholar
• 118 Maffiuletti NA, Minetto MA, Farina D, Bottinelli R. Electrical stimulation for neuromuscular testing and training: state-of-the art and unresolved issues. Eur J Appl Physiol 2011; 111 (10) 2391-2397
  CrossrefPubMedGoogle Scholar
• 119 Milner-Brown HS, Miller RG. Muscle strengthening through electric stimulation combined with low-resistance weights in patients with neuromuscular disorders. Arch Phys Med Rehabil 1988; 69 (1) 20-24
  PubMedGoogle Scholar
• 120 Chisari C, Bertolucci F, Dalise S, Rossi B. Chronic muscle stimulation improves muscle function and reverts the abnormal surface EMG pattern in myotonic dystrophy: a pilot study. J Neuroeng Rehabil 2013; 10 (1) 94
  CrossrefPubMedGoogle Scholar
• 121 National Cancer Institute. Electrostimulation of shoulder girdle and quadriceps muscles in facioscapulohumeral muscular dystrophy patient. NCT00821548. Available at: http://clinicaltrials.gov . Accessed November 1, 2014
  PubMedGoogle Scholar
• 122 National Cancer Institute. Duchenne muscular dystrophy clinical trial NCT01874275. Available at: http://clinicaltrials.gov . Accessed November 1, 2014
  PubMedGoogle Scholar
• 123 Skura CL, Fowler EG, Wetzel GT, Graves M, Spencer MJ. Albuterol increases lean body mass in ambulatory boys with Duchenne or Becker muscular dystrophy. Neurology 2008; 70 (2) 137-143
  CrossrefPubMedGoogle Scholar
• 124 Dorchies OM, Wagner S, Vuadens O , et al. Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy. Am J Physiol Cell Physiol 2006; 290 (2) C616-C625
  PubMedGoogle Scholar
• 125 Call JA, Voelker KA, Wolff AV , et al. Endurance capacity in maturing mdx mice is markedly enhanced by combined voluntary wheel running and green tea extract. J Appl Physiol (1985) 2008; 105 (3) 923-932
  CrossrefPubMedGoogle Scholar
• 126 Davoodi J, Markert CD, Voelker KA, Hutson SM, Grange RW. Nutrition strategies to improve physical capabilities in Duchenne muscular dystrophy. Phys Med Rehabil Clin N Am 2012; 23 (1) 187-199 , xii–xiii
  CrossrefPubMedGoogle Scholar
• 127 Chan A, Reichmann H, Kögel A, Beck A, Gold R. Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy. J Neurol 1998; 245 (10) 681-685
  CrossrefPubMedGoogle Scholar
• 128 Chen RS, Huang CC, Chu NS. Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study. Eur Neurol 1997; 37 (4) 212-218
  CrossrefPubMedGoogle Scholar
• 129 Spurney CF, Rocha CT, Henricson E , et al; Cooperative International Neuromuscular Research Group Investigators. CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy. Muscle Nerve 2011; 44 (2) 174-178
  CrossrefPubMedGoogle Scholar
• 130 Tarnopolsky MA. Potential benefits of creatine monohydrate supplementation in the elderly. Curr Opin Clin Nutr Metab Care 2000; 3 (6) 497-502
  CrossrefPubMedGoogle Scholar
• 131 Casey A, Greenhaff PL. Does dietary creatine supplementation play a role in skeletal muscle metabolism and performance?. Am J Clin Nutr 2000; 72 (2, Suppl): 607S-617S
  PubMedGoogle Scholar
• 132 Kley RA, Tarnopolsky MA, Vorgerd M. Creatine for treating muscle disorders. Cochrane Database Syst Rev 2011; (2) CD004760
  PubMedGoogle Scholar
• 133 Adamo CM, Dai DF, Percival JM , et al. Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 2010; 107 (44) 19079-19083
  CrossrefPubMedGoogle Scholar
• 134 National Cancer Institute. Protein supplementation and exercise in patients with FSH muscular dystrophy- a randomized placebo controlled study. NCT01618331. Available at: http://clinicaltrials.gov . Accessed November 1, 2014
  PubMedGoogle Scholar